Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-148372
Filing Date
2017-04-28
Accepted
2017-04-28 16:33:03
Documents
7
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d316345ddefa14a.htm DEFA14A 33298
2 GRAPHIC g317405g05e15.jpg GRAPHIC 23408
3 GRAPHIC g317405g16q56.jpg GRAPHIC 13701
4 GRAPHIC g317405g62d05.jpg GRAPHIC 24728
5 GRAPHIC g317405g76c99.jpg GRAPHIC 32714
6 GRAPHIC g317405g87n84.jpg GRAPHIC 13084
7 GRAPHIC g317405g98q07.jpg GRAPHIC 27964
  Complete submission text file 0001193125-17-148372.txt   221635
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36199 | Film No.: 17796134
SIC: 2834 Pharmaceutical Preparations